Home Sitemap Sitemap Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Solutions Sectors Therapeutics Insights News & Events About ICON Solutions Consulting and advisory services Toggle Consulting and advisory services Externalised development Asset Development Consulting Toggle Asset Development Consulting Adaptive trials Dose optimisation strategies Due diligence and asset valuation Nonclinical and pre clinical development Novel statistical methods Protocol optimisation Target product profile Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Toggle Clinical & Scientific Operations Accelerated study start-up Biostatistics and Programming Clinical Operations Data Monitoring Committee Services Clinical Supplies Management Clinical data science Endpoint Adjudication Services Global Logistics Interactive Response Technology Investigator Payments Medical Affairs Medical Call Centre Services Medical Writing Pharmacovigilance Project and Program Management Commercial Positioning Toggle Commercial Positioning Health Economics and Outcomes Research Market Access Market Research & Analytics Medical & Value Communications Patient Reported Outcomes Decentralised Clinical Trials Toggle Decentralised Clinical Trials In-Home Services Early Clinical Toggle Early Clinical Accelerated Pharmaceutical Solutions Bioanalytical Laboratories Biometrics Clinical Pharmacology Clinical Research Facilities Early Phase Oncology Ethnic Bridging Studies Medical Affairs Early Phase Patient Studies Early Phase Obesity Trials Quality and Compliance TQT studies Quantitative Pharmacology and Pharmacometrics Healthy Participant Recruitment Language Services Toggle Language Services Clinical and Medical Translations Linguistic Validation Translation Technologies Laboratories Toggle Laboratories LabView360 training resources Bioanalytical Laboratories Central Laboratories Specialty Biomarker Laboratories Biospecimen Services Biotech Laboratory Solutions Medical Imaging Toggle Medical Imaging Collect and hold Imaging therapeutic expertise Rescue studies Technology platforms Outcome Measures Toggle Outcome Measures Clinical Outcome Assessments Digital Health Technologies eCOA Technology Real World Intelligence Toggle Real World Intelligence Clinical Trial Tokenisation Real World Evidence and Late Phase Research RWE Strategy and Analytics Regulatory Affairs Toggle Regulatory Affairs Global Clinical Trials Regulatory Project Services Global Regulatory Strategy CMC & Quality Services Regulatory Operations Global Labelling & Ad Promotion Medical Device and Diagnostics Clinical Diagnostics Regulatory Affairs: IVD/CDx Symphony Health data Toggle Symphony Health data Symphony Health Conference Posters Health technology and business intelligence solutions Integrated Dataverse and Source Solutions Optimise brand strategy and sales effectiveness Solve market access challenges Understand the patient journey Making Medicines More Affordable Site & Patient Solutions Toggle Site & Patient Solutions Patient Centred Services Site & patient obesity solutions Sites Strategic Solutions Toggle Strategic Solutions Careers in Strategic Solutions Data-enabled FSP Organisational design Technology-led innovation Technologies Toggle Technologies AI at ICON WorkBench LabView360 CARD Signet ARCADES FIRECREST ICON Digital Platform OneView ICON ORCA Safety Evidence Platform Control Tower FLEX ADVANTAGE Medical Imaging Technology ICON ORCA Safety NONMEM Clinical Data Studio PDx-POP PubsHub SIMS ICOMaster for eTMF Prism Connect SmartDraft HORIZON Sectors Biotech Toggle Biotech Behind Biotech: Stories of science and resilience Early phase challenges for biotechs Early phase development: Understanding key obstacles for biotechs in 2024 Emerging biotech funding Externalised development for biotechs Early engagement and regulatory considerations for biotech De-risking clinical development of precision medicines in oncology Methods and technologies advancing Alzheimer’s and Parkinson’s R&D ICON survey report: CNS therapeutic development 2025 biotech survey report 2025 Global biotech survey report 2025 China biotech survey report Government and Public Health Toggle Government and Public Health Our experience on the ground in Africa Who we work with IGP services Public Health Medical Device Toggle Medical Device Clinical Operations Device & Therapeutic Expertise QA Support EU Regulations Pharmaceuticals Toggle Pharmaceuticals Mid-size pharma Partnerships Therapeutics Biosimilars Toggle Biosimilars Clinical trial development planning Cardiovascular Cell and Gene Therapies Central Nervous System Toggle Central Nervous System CNS Neurology CNS Pain CNS Psychiatry Challenges and opportunities in traumatic brain injury clinical trials Challenges and opportunities in Parkinson’s Disease clinical trials Key considerations in chronic pain clinical trials Endocrine & Metabolic Disorders Hepatology Toggle Hepatology The voice of NASH investigators Infectious Diseases Toggle Infectious Diseases Antimicrobial resistance HIV Pandemic respiratory vaccine clinical trials Internal Medicine & Immunology Toggle Internal Medicine & Immunology Dermatology Gastrointestinal Ophthalmology Respiratory Rheumatology Transplant Immunology Urology Medical Device Obesity Oncology Toggle Oncology Early Phase Oncology Immuno-Oncology Pediatrics Rare & Orphan Diseases Toggle Rare & Orphan Diseases Leveraging historical data for use in rare disease trials Patient centricity in orphan drug development Vaccines Toggle Vaccines Pandemic respiratory vaccine clinical trials Women's Health Therapeutics insights Toggle Therapeutics insights Biosimilars Cardiovascular Cell and Gene Therapies Central Nervous System Glycomics Infectious Diseases Hepatology Women's Health Insights Oncology Pediatrics Rare and orphan diseases Insights Digital Disruption Toggle Digital Disruption Clinical strategies to optimise SaMD for treating mental health Digital Disruption: Surveying the industry's evolving landscape AI and clinical trials Clinical trial data anonymisation and data sharing Clinical Trial Tokenisation Closing the evidence gap: The value of digital health technologies in supporting drug reimbursement decisions mHealth wearables Personalising Digital Health Real World Data The triad of trust: Navigating real-world healthcare data integration Decoding AI in software as a medical device (SaMD) Software as a medical device (SaMD) Patient Centricity Toggle Patient Centricity Accelerating clinical development through DHTs Agile Clinical Monitoring Capturing the voice of the patient in clinical trials Charting the Managed Access Program Landscape Representation and inclusion in clinical trials Exploring the patient perspective from different angles Patient safety and pharmacovigilance Patient voice survey Patient Voice Survey - Decentralised and Hybrid Trials Reimagining Patient-Centricity with the Internet of Medical Things (IoMT) Using longitudinal qualitative research to capture the patient voice Prioritising patient-centred research for regulatory approval Regulatory Intelligence Toggle Regulatory Intelligence Accelerating access Meeting requirements for Joint Clinical Assessments Navigating the regulatory landscape in the US and Japan: Preparing for ICH GCP E6(R3) implementation An innovative approach to rare disease clinical development EU Clinical Trials Regulation Using innovative tools and lean writing processes to accelerate regulatory document writing Current overview of data sharing within clinical trial transparency Global Agency Meetings: A collaborative approach to drug development Keeping the end in mind: key considerations for creating plain language summaries Navigating orphan drug development from early phase to marketing authorisation Procedural and regulatory know-how for China biotechs in the EU RACE for Children Act Early engagement and regulatory considerations for biotech Regulatory Intelligence Newsletter Spotlight on regulatory reforms in China Demystifying EU CTR, MDR and IVDR Transfer of marketing authorisation Exploring FDA guidance for modern Data Monitoring Committees Streamlining dossier preparation Therapeutics insights Toggle Therapeutics insights Endocrine and Metabolic Disorders Cardiovascular Cell and Gene Therapies Central Nervous System Glycomics Infectious Diseases NASH Obesity Oncology Paediatrics Respiratory Rare and orphan diseases Transforming Trials Toggle Transforming Trials Accelerating biotech innovation from discovery to commercialisation Demystifying the Systematic Literature Reviews Ensuring the validity of clinical outcomes assessment (COA) data: The value of rater training From bottlenecks to breakthroughs Linguistic validation of Clinical Outcomes Assessments More than monitoring Optimising biotech funding Adaptive clinical trials Best practices to increase engagement with medical and scientific poster content Decentralised clinical trials eCOA implementation Blended solutions insights Implications of COVID-19 on statistical design and analyses of clinical studies Improving pharma R&D efficiency Increasing Complexity and Declining ROI in Drug Development Partnership insights Transforming the R&D Model to Sustain Growth Value Based Healthcare Toggle Value Based Healthcare Building a comparative evidence base using network meta-analysis Strategies for commercialising oncology treatments for young adults US payers and PROs Accelerated early clinical manufacturing CMS Part D Price Negotiations: Is your drug on the list? Ensuring scientific rigor in external control arms Evidence Synthesis: A solution to sparse evidence, heterogeneous studies, and disconnected networks Health technology assessment Perspectives from US payers Medical communications in early phase product development Payer Reliance on ICER and Perceptions on Value Based Pricing Precision Medicine RWE Generation Cross Sectional Studies and Medical Chart Review The Role of ICER as an HTA Organisation Integrating openness and precision for competitive advantage Blog Videos Webinar Channel News & Events Press releases In the News Mediakit Toggle Mediakit Facts and figures ICON spokespeople Awards Events Toggle Events Industry events Webinars Workshops Webinars Social media hub About ICON Brazil Pay Transparency Reports Privacy and Data notices Site cookies Company history ICON at a glance Patients Healthy participants ICON in Asia Pacific Toggle ICON in Asia Pacific Japan India China Investigators Toggle Investigators Clinical Study Investigators Early Phase Investigator Site Resource Centre Register Transparency - Loi Bertrand Legislation ICON in Latin America Jobs & Careers Investors Leadership Toggle Leadership Board of Directors Quality Suppliers Environmental, Social and Governance Toggle Environmental, Social and Governance Environment Governance Social
